open access

Vol 13, No 2 (2010)
Case report
Published online: 2011-05-20
Submitted: 2012-01-23
Get Citation

Abnormal Tc99m sulesomab in Klippel-Trenaunay syndrome

Shabina Begum, Ewa Nowosinska, John R. Buscombe
Nucl. Med. Rev 2010;13(2):84-86.

open access

Vol 13, No 2 (2010)
Case Report
Published online: 2011-05-20
Submitted: 2012-01-23

Abstract

Tc-99m sulesomab is indicated in bone and joint infection, but reading of scans can be affected by pre-existing conditions. This case report describes a case of Klippel-Trenaunay syndrome (KTS) which results in vascular malformations of one or more limbs. Tc-99m sulesomab imaging demonstrated persistent blood pool activity up to 20 hours post injection. However, despite this, septic arthritis could be identified with confidence in the same limb.
Nuclear Med Rev 2010; 13, 2: 84–86

Abstract

Tc-99m sulesomab is indicated in bone and joint infection, but reading of scans can be affected by pre-existing conditions. This case report describes a case of Klippel-Trenaunay syndrome (KTS) which results in vascular malformations of one or more limbs. Tc-99m sulesomab imaging demonstrated persistent blood pool activity up to 20 hours post injection. However, despite this, septic arthritis could be identified with confidence in the same limb.
Nuclear Med Rev 2010; 13, 2: 84–86
Get Citation

Keywords

Klippel-Trenaunay syndrome; Tc-99m sulesomab

About this article
Title

Abnormal Tc99m sulesomab in Klippel-Trenaunay syndrome

Journal

Nuclear Medicine Review

Issue

Vol 13, No 2 (2010)

Article type

Case report

Pages

84-86

Published online

2011-05-20

Bibliographic record

Nucl. Med. Rev 2010;13(2):84-86.

Keywords

Klippel-Trenaunay syndrome
Tc-99m sulesomab

Authors

Shabina Begum
Ewa Nowosinska
John R. Buscombe

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl